SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950162-09-000089
Filing Date
2009-02-20
Accepted
2009-02-20 14:09:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA/SIGMA TAU PHARMACEUTICALS SCHEDULE 13D - 02/11/09 sigmataupharm13d_021109.htm SC 13D 236538
  Complete submission text file 0000950162-09-000089.txt   238672
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39976 | Film No.: 09624552
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877
Business Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877 1-800-447-0169
Sigma-Tau Pharmaceuticals, Inc. (Filed by) CIK: 0001385625 (see all company filings)

IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D